Sante products and prices in Pakistan
Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.
Follow price changes 🔒 Company report (Pharma Pro)Private pharmaceutical manufacturer · Karachi · Pakistan
Karachi specialty pharmaceutical manufacturer established in 1996 with strong ophthalmology, dermatology, ENT and general-medicine portfolios.
Sante products in Pakistan
Sante (Private) Limited has 55 medicine presentations registered in Pakistan under 38 brands, covering 29 generic medicines. Most of its products are in Anti-infectives, Ophthalmology and Dermatology. Its brands with the most registered strengths and packs are Otoflox Ear (Ofloxacin), Sanflucan (Fluconazole), Zithrosan (Azithromycin) and Betalol Eye (Timolol). 55 products have an official DRAP price on MedInfoBase. See all 38 brands A to Z
What is sourced, and how recent is it?
Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.
Company profile
- Company type
- Private pharmaceutical manufacturer
- Address
- 39-C/1, Block 6, P.E.C.H.S., Karachi 75400, Pakistan · 75400
- Website
- sante.com.pk ↗
- Phone
- +92 21 38679761-64
- sante@sante.com.pk
- Official contact
- Contact page ↗
- Corporate source details checked
- 15 Oct 2026
- Corporate profile completeness
- 100%
Company location
A sourced company location is recorded. Use the map link below for directions.
Portfolio at a glance
RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.
PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.
IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.
Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.
Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.
Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.
How complete is this profile?
Downloadable company intelligence charts
Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.
Therapeutic Portfolio Mix
Shows where the company portfolio is concentrated across broad therapeutic areas.
Portfolio distribution, not sales or market-share data.
Dosage Form Portfolio
Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.
Counts are product presentations, not production or sales volumes.
Equivalent Price Position
Shows whether safely comparable products are below, near or above the peer median unit price.
This is price-position intelligence, not sales, demand or market-share data.
Closest Portfolio Competitors
Highlights other manufacturers with the greatest generic overlap with this company portfolio.
Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.
Therapeutic areas
High-level clinical areas represented by this company’s current MedInfoBase portfolio.
Drug classes
More specific classes derived from the canonical generic and preserved curated classifications.
Dosage forms
How MedInfoBase classifies the portfolio
MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.
Deepest brand families
Unit-price positioning vs equivalent products
See where Sante (Private) Limited is priced against the market
48 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.
How MedInfoBase calculates price position
Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.
Portfolio overlap
Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.
🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock
Observed database signals
These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.
Medicine portfolio
This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.
| Brand | Generic | Strength | Form | Pack | Registration | Source-listed price | Unit price | Price position |
|---|---|---|---|---|---|---|---|---|
| Acetamide | Acetazolamide | 250 mg | Tablet | 30's | 097086 | PKR 328.65 | PKR 10.96/tablet | 🔒 Pharma Pro |
| Bakcin | Ciprofloxacin | 3 mg/mL | Ophthalmic solution | 5ml | 030361 | PKR 219.94 | PKR 43.99/mL | 🔒 Pharma Pro |
| Betalol Eye | Timolol | 5.0 mg | Solution | 10ml | 021610 | PKR 239.35 | PKR 23.94/mL | No comparator |
| Betalol Eye | Timolol | 5.0 mg/mL | Solution | 5ml | 021610 | PKR 197.07 | PKR 39.41/mL | No comparator |
| Betasan | Betamethasone dipropionate | 0.64 mg | Ointment | 15gm | 037901 | PKR 109.62 | PKR 7.31/g | No comparator |
| Claraze | Clarithromycin | 250 mg | Tablet | 10's | 073446 | PKR 526.21 | PKR 52.62/tablet | 🔒 Pharma Pro |
| Claraze | Clarithromycin | 500 mg | Tablet | 10's | 073447 | PKR 919.08 | PKR 91.91/tablet | 🔒 Pharma Pro |
| Diprosan | Betamethasone dipropionate | 0.64 mg | Cream | 10gm | 027077 | PKR 156.35 | PKR 15.64/g | 🔒 Pharma Pro |
| Dipsan 10mg TabletEach | Amlodipine | 10 mg | Tablet | 20's | 081459 | PKR 313.43 | PKR 15.67/tablet | 🔒 Pharma Pro |
| Dipsan 5mg TabletEach | Amlodipine | 5 mg | Tablet | 20's | 081458 | PKR 213.80 | PKR 10.69/tablet | 🔒 Pharma Pro |
| Floxasan | Levofloxacin | 250 mg | Tablet | 10's | 090929 | PKR 485.37 | PKR 48.54/tablet | 🔒 Pharma Pro |
| Floxasan | Levofloxacin | 500 mg | Tablet | 10's | 090930 | PKR 807.65 | PKR 80.77/tablet | 🔒 Pharma Pro |
| Hyoxlin | Hydroxychloroquine | 200 mg | Tablet | 50's | 104419 | PKR 675.31 | PKR 13.51/tablet | 🔒 Pharma Pro |
| Hyoxlin | Hydroxychloroquine | 200 mg | Tablet | 30's | 104419 | PKR 405.19 | PKR 13.51/tablet | 🔒 Pharma Pro |
| Lopnar 200 | Lopinavir + Ritonavir | 200 mg + 50 mg | Tablet | 120's | 104421 | PKR 11,525.22 | PKR 96.04/tablet | 🔒 Pharma Pro |
| Lumerax | Artemether + Lumefantrine | 20 mg + 120 mg | Tablet | 16's | 073448 | PKR 660.91 | PKR 41.31/tablet | 🔒 Pharma Pro |
| Lumerax Forte | Artemether + Lumefantrine | 40 mg + 240 mg | Tablet | 8's | 073449 | PKR 578.85 | PKR 72.36/tablet | 🔒 Pharma Pro |
| Lumerax Forte | Artemether + Lumefantrine | 40 mg + 240 mg | Tablet | 10's | 073449 | PKR 679.65 | PKR 67.97/tablet | 🔒 Pharma Pro |
| Megamox | Moxifloxacin | 200 mg | Tablet | 10's | 039285 | PKR 484.33 | PKR 48.43/tablet | 🔒 Pharma Pro |
| Mupream | Mupirocin | 20 mg | Cream | 15gm | 076451 | PKR 230.35 | PKR 15.36/g | 🔒 Pharma Pro |
| Natasan | Natamycin | 50.0 mg/mL | Suspension | 5ml | 024659 | PKR 408.35 | PKR 81.67/mL | No comparator |
| Netarsu Ophthalmic Solution 0.02%Registry verified | Netarsudil Dimesylate Eq. to Netarsudil | — | — | — | 137131Official source ↗ | No indexed price | — | — |
| Noxzim Skin CreamRegistry verified | Clobetasol propionate | — | — | — | 030357Official source ↗ | No indexed price | — | — |
| Optoflox | Ofloxacin | 3 mg/mL | Ophthalmic solution | 5ml | 007501 | PKR 168.44 | PKR 33.69/mL | 🔒 Pharma Pro |
| Optoflox | Ofloxacin | 0.3% | Ophthalmic ointment | 3.5gm | 021608 | PKR 195.12 | PKR 55.75/g | 🔒 Pharma Pro |
| Optopred | Prednisolone | 10 mg/mL | Suspension | 5ml | 021607 | PKR 131.13 | PKR 26.23/mL | 🔒 Pharma Pro |
| Otoflox Ear | Ofloxacin | 0.3 % | Ear drops | 5ml | 026137 | PKR 161.93 | PKR 32.39/mL | 🔒 Pharma Pro |
| Otoflox Ear | Ofloxacin | 0.3 % | Ear drops | 10ml | 026137 | PKR 273.63 | PKR 27.36/mL | 🔒 Pharma Pro |
| Otoflox Ear | Ofloxacin | 0.6 % | Ear drops | 5ml | 026138 | PKR 273.63 | PKR 54.73/mL | 🔒 Pharma Pro |
| Otoflox Ear | Ofloxacin | 0.6 % | Ear drops | 10ml | 026138 | PKR 478.85 | PKR 47.89/mL | 🔒 Pharma Pro |
| Permisan | Permethrin | 5% | Lotion | 60ml | 061886 | PKR 170.61 | PKR 2.84/mL | 🔒 Pharma Pro |
| Permisan | Permethrin | 5% | Cream | 30gm | 061887 | PKR 82.59 | PKR 2.75/g | 🔒 Pharma Pro |
| Prolotic Otic | Ciprofloxacin | 0.3 % | Ear drops | 5ml | 073452 | PKR 196.21 | PKR 39.24/mL | 🔒 Pharma Pro |
| Quilinol | Chloroquine | 250 mg | Tablet | 500's | 104420 | PKR 615.43 | PKR 1.23/tablet | 🔒 Pharma Pro |
| Rosan 10mg TabletRegistry verified | Rosuvastatin calcium equivalent to Rosuvastatin | — | — | — | 081462Official source ↗ | No indexed price | — | — |
| Rosan 20mg TabletRegistry verified | Rosuvastatin calcium equivalent to Rosuvastatin | — | — | — | 081460Official source ↗ | No indexed price | — | — |
| Sanflucan | Fluconazole | 50 mg | Capsule | 7's | 086044 | PKR 916.28 | PKR 130.90/capsule | 🔒 Pharma Pro |
| Sanflucan | Fluconazole | 200 mg | Capsule | 4's | 086046 | PKR 1,004.79 | PKR 251.20/capsule | 🔒 Pharma Pro |
| Sanflucan | Fluconazole | 150 mg | Capsule | 1's | 088917 | PKR 282.92 | PKR 282.92/capsule | 🔒 Pharma Pro |
| Santobrex | Tobramycin | 3 mg/mL | Ophthalmic solution | 5ml | 026912 | PKR 223.31 | PKR 44.66/mL | No comparator |
| Santomox | Moxifloxacin | 400 mg | Tablet | 5's | 037031 | PKR 994.59 | PKR 198.92/tablet | 🔒 Pharma Pro |
| Santosel | Oseltamivir | 75 mg | Capsule | 10's | 104422 | PKR 1,125.52 | PKR 112.55/capsule | 🔒 Pharma Pro |
| Santovir | Aciclovir | 30 mg/g | Ophthalmic ointment | 4.5gm | 023325 | PKR 300.45 | PKR 66.77/g | 🔒 Pharma Pro |
| Santovir | Aciclovir | 800 mg | Tablet | 10's | 027081 | PKR 2,104.83 | PKR 210.48/tablet | 🔒 Pharma Pro |
| Santovir Skin | Aciclovir | 5 % | Cream | 10gm | 027080 | PKR 513.31 | PKR 51.33/g | 🔒 Pharma Pro |
| Sanzol | Omeprazole | 20 mg | Capsule | 14's | 086047 | PKR 293.20 | PKR 20.94/capsule | 🔒 Pharma Pro |
| Sanzol | Omeprazole | 40 mg | Capsule | 2x7's | 086048 | PKR 509.05 | PKR 36.36/capsule | 🔒 Pharma Pro |
| Sanzole Skin | Clotrimazole | 10 mg | Cream | 10gm | 030353 | PKR 68.17 | PKR 6.82/g | 🔒 Pharma Pro |
| Terbisan | Terbinafine | 10 mg | Cream | 10gm | 027076 | PKR 294.42 | PKR 29.44/g | 🔒 Pharma Pro |
| Tropic | Tropicamide | 10 mg/mL (1%) | Ophthalmic drops | 15ml | 023328 | PKR 250.37 | PKR 16.69/mL | No comparator |
All 38 Sante brands in Pakistan
- Acetamide Acetazolamide · 250 mg tablet
- Bakcin Ciprofloxacin · 3 mg/mL solution
- Betalol Eye Timolol · 5.0 mg solution, 5.0 mg/mL solution
- Betasan Betamethasone dipropionate · 0.64 mg ointment
- Claraze Clarithromycin · 250 mg tablet, 500 mg tablet
- Diprosan Betamethasone dipropionate · 0.64 mg cream
- Dipsan 10mg TabletEach Amlodipine · 10 mg tablet
- Dipsan 5mg TabletEach Amlodipine · 5 mg tablet
- Floxasan Levofloxacin · 250 mg tablet, 500 mg tablet
- Hyoxlin Hydroxychloroquine · 200 mg tablet
- Lopnar 200 Lopinavir + Ritonavir · 200 mg + 50 mg tablet
- Lumerax Artemether + Lumefantrine · 20 mg + 120 mg tablet
- Lumerax Forte Artemether + Lumefantrine · 40 mg + 240 mg tablet
- Megamox Moxifloxacin · 200 mg tablet
- Mupream Mupirocin · 20 mg cream
- Natasan Natamycin · 50.0 mg/mL suspension
- Optoflox Ofloxacin · 0.3% ointment, 3 mg/mL solution
- Optopred Prednisolone · 10 mg/mL suspension
- Otoflox Ear Ofloxacin · 0.3 % drops, 0.6 % drops
- Permisan Permethrin · 5% cream, 5% lotion
- Prolotic Otic Ciprofloxacin · 0.3 % drops
- Quilinol Chloroquine · 250 mg tablet
- Sanflucan Fluconazole · 150 mg capsule, 200 mg capsule, 50 mg capsule
- Santobrex Tobramycin · 3 mg/mL solution
- Santomox Moxifloxacin · 400 mg tablet
- Santosel Oseltamivir · 75 mg capsule
- Santovir Aciclovir · 30 mg/g ointment, 800 mg tablet
- Santovir Skin Aciclovir · 5 % cream
- Sanzol Omeprazole · 20 mg capsule, 40 mg capsule
- Sanzole Skin Clotrimazole · 10 mg cream
- Terbisan Terbinafine · 10 mg cream
- Tropic Tropicamide · 10 mg/mL (1%) drops
- Vibsan Doxycycline · 50 mg capsule
- Vislat Latanoprost · 50 mcg/mL drops
- Xolisan Nasal Spray Xylometazoline · 1 mg spray
- Zeproquin Ciprofloxacin · 250 mg tablet, 500 mg tablet
- Zithrosan Azithromycin · 250 mg capsule, 500 mg tablet, 500 mg capsule
- Zithrosan 1% Eye Azithromycin · 1 % drops
Sante: common questions
How many products does Sante have in Pakistan?
Sante (Private) Limited has 55 registered medicine presentations in Pakistan, sold under 38 brands and covering 29 generic medicines.
What are the main brands of Sante?
By number of registered strengths and packs, its largest brands are Otoflox Ear (Ofloxacin), Sanflucan (Fluconazole), Zithrosan (Azithromycin), Betalol Eye (Timolol) and Claraze (Clarithromycin). This is not a sales ranking.
Which therapy areas does Sante cover?
The most products are in Anti-infectives (41), Ophthalmology (5), Dermatology (3), Cardiovascular (2) and Gastrointestinal & hepatology (2).
Where can I see Sante medicine prices?
Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.
MedInfoBase company-intelligence methodology
This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.
Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.
Cite this record
Manufacturer recordRecords change over time. Please cite the access date so readers can locate the version you used.